Volver al artículo.

Referencias para el artículo

1. Sklar SH, Blue WT, Alexander EJ, et al. Herpes zoster. The treatment and prevention of neuralgia with adenosine monophosphate. JAMA 1985;253:1427-30.
2. Gajdos A. AMP in porphyria cutanea tarda. Lancet 1974;I:163 [letter].
3. Bakshi F, Barzilay Z, Paret G, Hashomer T. Adenosine in the diagnosis and treatment of narrow complex tachycardia in the pediatric intensive care unit. Heart Lung 1998;27:47-50.
4. Camaiti A, Del Rosso A, Morettini A, et al. Efficacy and safety of adenosine in diagnosis and treatment of regular tachycardia in the elderly. Coron Artery Dis 1998;9:591-6.
5. Schrader J, Deussen A, Smolenski RT. Adenosine is a sensitive oxygen sensor in the heart. Experientia 46:1172-5.
6. Headrick J, Willis RJ. Endogenous adenosine improves work rate to oxygen consumption ratio in catecholamine stimulated isovolumic rat heart. Pflugers Arch 1989;413:354-8.
7. Finegan BA, Clanachan AS, Coulson CS, Lopaschunk GD. Adenosine modification of energy substrate use in isolated hearts perfused with fatty acids. Am J Physiol 1992;262:H1501-7.
8. Sklar SH. Herpes virus infection. JAMA 1977;237:871–2.
9. Sherlock CH, Corey L. Adenosine monophosphate for the treatment of varicella zoster infections: A large dose of caution. JAMA 1985;253:1444–5.
10. Gaby AR, Wright JV. Nutritional Therapy in Medical Practice. Proceedings from Nutritional Therapy in Medical Practice Conference, Seattle, WA, Oct 25–8, 1996, 33; gaby@halcyon.com.